Literature DB >> 5414404

Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.

R Alexanian, P J Migliore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5414404

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  7 in total

1.  Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma.

Authors:  E Kastritis; F Zagouri; A Symeonidis; M Roussou; A Sioni; A Pouli; S Delimpasi; E Katodritou; E Michalis; M Michael; E Hatzimichael; A Vassou; P Repousis; A Christophoridou; Z Kartasis; E Stefanoudaki; C Megalakaki; S Giannouli; M-C Kyrtsonis; K Konstantopoulos; M Spyroupoulou-Vlachou; E Terpos; M A Dimopoulos
Journal:  Leukemia       Date:  2014-03-18       Impact factor: 11.528

2.  In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities.

Authors:  H Mellstedt; G Holm
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

3.  T-cell imbalances in patients with multiple myeloma: an analysis by monoclonal antibodies.

Authors:  C D Platsoucas; H J Hansen; J R Redman; S Berenson; B J Lee; B D Clarkson
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

4.  Polyclonal immunoglobulin deficiency in myelomatosis and macroglobulinaemia.

Authors:  M T Cwynarski; S Cohen
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

5.  PWM-induced generation of immunoglobulin-secreting cells in patients with multiple myeloma.

Authors:  G Sieber; B Enders; H Rühl
Journal:  Klin Wochenschr       Date:  1981-10-01

6.  The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma.

Authors:  Murat Sarı; Selma Sarı; Meliha Nalçacı
Journal:  Turk J Haematol       Date:  2016-10-31       Impact factor: 1.831

7.  Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials.

Authors:  Jennifer L J Heaney; John P Campbell; Gulnaz Iqbal; David Cairns; Alex Richter; J Anthony Child; Walter Gregory; Graham Jackson; Martin Kaiser; Roger Owen; Faith Davies; Gareth Morgan; Janet Dunn; Mark T Drayson
Journal:  Leukemia       Date:  2018-06-20       Impact factor: 11.528
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.